 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Topical (cream, gel, spray) |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 98–99% |
| Metabolites | Flufenamic acid, hydroxyl derivatives |
| Excretion | 35% renal, mostly biliary |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.045.650  |
| Chemical and physical data | |
| Formula | C18H18F3NO4 |
| Molar mass | 369.340 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Etofenamate is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of joint and muscular pain. It is available for topical application as a cream, a gel or as a spray.
Etofenamate is acutely toxic if swallowed; it is also very toxic to aquatic life, with long lasting effects.
References
- Chlud K (1999). "". Wiener Medizinische Wochenschrift (in German). 149 (19–20): 546–7. PMID 10637963.
- "Etofenamate". PubChem.
| Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
|---|---|
| pyrazolones / pyrazolidines | |
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
| Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
| Topical products for joint and muscular pain (M02) | |||||||
|---|---|---|---|---|---|---|---|
| Anti-inflammatory preparations, non-steroids |
| ||||||
| Capsaicin derivatives | |||||||
| Other | |||||||
 | This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |